| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2001 | EP1063885A1 Xylitol compositions for treating upper respiratory conditions |
| 01/03/2001 | EP0934060A4 Dietary supplements |
| 01/03/2001 | EP0902624B1 Composition and its use as a food supplement or for lowering lipids in serum |
| 01/03/2001 | EP0842169B1 Benzothiophene compounds |
| 01/03/2001 | EP0832057B1 Diaromatic propynyl or dienyl compounds |
| 01/03/2001 | EP0828706B1 Amide derivatives and external skin or hair care preparations |
| 01/03/2001 | EP0811375B1 Glutamic acid receptor agonist |
| 01/03/2001 | EP0807183B1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 01/03/2001 | EP0787127B1 5-lipoxygenase inhibitors |
| 01/03/2001 | EP0722312B1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 01/03/2001 | EP0708776B1 Antiallergic imidazoazepines |
| 01/03/2001 | EP0662822B1 Two-phase matrix for sustained release drug delivery device |
| 01/03/2001 | EP0656890B1 Novel method for preparing ergothioneine |
| 01/03/2001 | EP0637244B1 A strain of streptomyces avermitilis glycosylates avermectin compounds |
| 01/03/2001 | CN1278865A Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 01/03/2001 | CN1278825A Sarcodictyin and eleutherobin useful for stabilising microtubules |
| 01/03/2001 | CN1278823A 1'-[4-[1-(4-Fluorophenyl)-1(H)-indole-3-yl]-1-butyl]-spiro [isobenzofuran-1(3(H),4'-piperidine] hydrohalogenides |
| 01/03/2001 | CN1278822A 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/03/2001 | CN1278821A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278820A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278819A Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating and stress-related |
| 01/03/2001 | CN1278817A S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
| 01/03/2001 | CN1278815A 3-oxo-2(H)-1,2,4-triazine derivativs as ligands of 5HT1A receptors |
| 01/03/2001 | CN1278813A Antimicrobial quinolones, their compositions and uses |
| 01/03/2001 | CN1278812A 2-aryl-3-aroylbenzo [b] thiophenes for treatment of estrin deficiency |
| 01/03/2001 | CN1278811A 2-Arylbenzo[b] thiophenes useful for the treatment of estrogen deprivtion syndrome |
| 01/03/2001 | CN1278810A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278809A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278805A Novel heterocyclioally substituted and a-hydroxycarboxlic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
| 01/03/2001 | CN1278800A Cyclohexane derivatives difunctionalised in 1.4 as ligands of 5T hia receptors |
| 01/03/2001 | CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity |
| 01/03/2001 | CN1278796A Method for the synthesis of quinoline derivatives |
| 01/03/2001 | CN1278795A Process for making diaryl pyridines useful as cox-2 inhibitors |
| 01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
| 01/03/2001 | CN1278790A Chemical compound |
| 01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 01/03/2001 | CN1278785A Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
| 01/03/2001 | CN1278739A Method of delivering genes to antigen presenting cells of the skin |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278732A Anti-estrogen plus progestin containing oral contraceptives |
| 01/03/2001 | CN1278731A Use of mirtazapine for treating sleep apneas |
| 01/03/2001 | CN1278730A Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 01/03/2001 | CN1278729A A composition of a 5-HT reuptake inhibitor and a h5-HT 1B antagonist or partial agonist |
| 01/03/2001 | CN1278728A Compositions and methods for treating respiratory disorders |
| 01/03/2001 | CN1278727A A combination of a monomine oxidase inhibitor and a hs-ht antagonist or partial agonist |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278725A Indeno [1,2-c]-naphtho [1,2-C]- and benzo [6,7] cyclohepta [1,2-C] pyrazole derivatives |
| 01/03/2001 | CN1278724A Indeno [1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activty |
| 01/03/2001 | CN1278723A Percutaneously absorbable preparation |
| 01/03/2001 | CN1278722A 8a-azalides as veterinary antimicrobial agents for animals |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1278430A Composite Triamcinolone Acetonide medicine for treating germ-free inflammation |
| 01/03/2001 | CN1278429A Controlled-releasing vaginal tinidazole collyrium and its preparation |
| 01/03/2001 | CN1060257C Cycloidal gear driving mechanism and apparatus |
| 01/03/2001 | CN1060177C 3'-monophosphorylated oligonucleotides |
| 01/03/2001 | CN1060175C Method for prepn. of 3-formyl-cephem derivatives |
| 01/03/2001 | CN1060173C Heterocyclic compound with activity against diabetes and preparation nad application of same |
| 01/03/2001 | CN1060172C Substituted biphenyl sulfonamide endothelin antagonists |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060168C Xanthene derivant, its preparation method and medicinal composition containing same |
| 01/03/2001 | CN1060164C SIN-IA cyclodextriun inclusion complexes |
| 01/03/2001 | CN1060163C Acylated aminoalknimidazoles and aminoalkyl triazoles |
| 01/03/2001 | CN1060162C Substituted benzene sulfone urea, benzenesulfonyl thiourea, its preparing method, application of preparation for producing medicine and drugs containing them |
| 01/03/2001 | CN1060083C Medicinal bolus for treating pulmonary tuberculosis and method for preparing same |
| 01/03/2001 | CN1060082C Medicine for treating tuberculosis of lymphnode, and method for preparing same |
| 01/03/2001 | CN1060045C Positive molecular bone intensifying agent and its producing technology |
| 01/03/2001 | CN1060043C Animal medicinal composition |
| 01/03/2001 | CN1060042C Stabilized prostaglandin E1 |
| 01/03/2001 | CN1060041C Aqueous composition |
| 01/03/2001 | CN1060040C A stable pharmaceutical composition of terfenadine and isuprofen |
| 01/03/2001 | CN1060039C Inhibition of smooth muscle cell migration by (R)-amlodipine |
| 01/03/2001 | CN1060038C Elemene emulsion injection and its preparing process |
| 01/02/2001 | US6169181 Compounds useful to treat retroviral infections |
| 01/02/2001 | US6169116 Amino-tetralines, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/02/2001 | US6169115 Substrates or substrate analogs for creatine kinase; |
| 01/02/2001 | US6169114 Endermic liniment containing a thiol compound and zinc oxide |
| 01/02/2001 | US6169113 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 01/02/2001 | US6169112 Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives |
| 01/02/2001 | US6169111 Conformationally rigid aryl prostaglandins for use in glaucoma therapy |
| 01/02/2001 | US6169110 Rejuvenating the skin using a combination of vitamin A and alphahydroxy acids |
| 01/02/2001 | US6169105 Potentiating the action of paroxetine in increasing the availability of serotonin, norepinephrine and dopamine in the brain by administering paroxetine to a patient in need thereof in combination with way 100635 |
| 01/02/2001 | US6169104 Compounds bind tubulin and exhibit anti-mitotic properties; using such compounds to inhibit abnormal cell mitosis and, in particular, to inhibit tumor cell growth |
| 01/02/2001 | US6169103 Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 01/02/2001 | US6169102 Oxazolone derivatives and their use as anti-Helicobacter pylori agent |
| 01/02/2001 | US6169100 Pharmaceutical composition |
| 01/02/2001 | US6169099 Pharmaceutical composition |
| 01/02/2001 | US6169098 Composition and methods employing it for the treatment of 5-HT-mediated disorders |
| 01/02/2001 | US6169097 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives |
| 01/02/2001 | US6169096 For inhibiting tumor growth in a mammal |
| 01/02/2001 | US6169095 For prevention and/or treatment of bradykinin or its analogues mediated diseases in the eye, such as allergy, inflammation and pain of the eye |
| 01/02/2001 | US6169094 Compositions of (S) (-)-amisulpride |
| 01/02/2001 | US6169093 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia |
| 01/02/2001 | US6169092 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes |
| 01/02/2001 | US6169091 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169089 Nitric oxide synthase inhibitors; treatment of arthritis |
| 01/02/2001 | US6169088 1,3 diazines with platelet-derived growth factor receptor inhibitory activity |